KILO DIABETES & VASCULAR RESEARCH FOUNDATION (EIN 237152540) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1972

Legal Domicile

Principal Officer

CHARLES KILO MD

Phone

3144346500

Tax Period

2018-01-01 to 2018-12-31

KILO DIABETES & VASCULAR RESEARCH FOUNDATION, founded in 1972, is a small nonprofit that reported $499K in total revenue in fiscal year 2018. Revenue surged 226% from the prior year, signaling strong growth momentum. Expenses of $949K exceeded revenue, resulting in a 90% operating deficit.

Mission

TO FIND A CURE FOR DIABETES, PRESERVE LIFE, PROMOTE HEALTH AND SAFEGUARD THE LIVES OF PEOPLE WITH DIABETES AND VASCULAR DISEASE THROUGH RESEARCH, EDUCATION, PROPER CARE AND TREATMENT.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2018)

Revenue Breakdown

Contributions & Grants $205,222

Program Service Revenue $0

Investment Income $293,670

Other Revenue $0

TOTAL REVENUE $498,892

Expense Breakdown

Grants Paid $900,000

Salaries & Benefits $0

Fundraising Expenses $48

Program Expenses $903,522

Other Expenses $48,981

TOTAL EXPENSES $948,981

Year-over-Year Comparison

	2018	2017	Change
Revenue	$498,892	$153,027	+2.3%
Expenses	$948,981	$1,178,446	-0.2%
Net Income	$-450,089	$-1,025,419	-0.6%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✓ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
CHARLES KILO MD	CHAIRMAN	40.00	Officer Director	$0	$0	$0
WILLIAM COURTNEY	DIRECTOR	0.00	Director	$0	$0	$0
TAREK DEIAB	DIRECTOR	0.00	Director	$0	$0	$0
JACK GARLAND	DIRECTOR	0.00	Director	$0	$0	$0
ROBERT J JOHNSON	DIRECTOR	0.00	Director	$0	$0	$0
JAMES OTIS SR	DIRECTOR	0.00	Director	$0	$0	$0
DENNIS PHILLIPS	DIRECTOR	0.00	Director	$0	$0	$0
J HOLT TIPTON III	SECRETARY	0.00	Officer Director	$0	$0	$0
TONY TWIST	DIRECTOR	0.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2018	$498,892	$948,981	$1,302,741	$-450,089

KILO DIABETES & VASCULAR RESEARCH FOUNDATION